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ABSTRACT

The platinum compound

(

)

Cl [Chloro[N,N-

diethyldiethylenetriamine] Platinum(II) Chloride] was synthesized and reacted with
N-acetylmethionine (N-AcMet) and guanosine 5’-monophosphate (5’-GMP).
Previous experiments show that N-AcMet reacts kinetically faster with the central
platinum atom and that 5’-GMP bonds slower yet stronger. When

(

)

Cl

was reacted with N-AcMet the N-AcMet displaced the chloride ion as expected.
When

(

)

Cl was reacted with 5’-GMP the 5’-GMP binds to the chloride

ion and the reaction is finished. Yet, when 5’-GMP was added in the solution already
containing N-AcMet, the N-AcMet was not displaced as predicted. Through 1H NMR
Spectroscopy and Mass Spectrometry we observed that the 5’-GMP also bonds to the
central platinum ion displacing one of the nitrogen atoms of the

chelate.

Multiple experiments were done adding different ratios of N-AcMet and 5’-GMP and
at different stages of the reaction. It was observed that the dominant product is the
same, and the reaction is complete in approximately 24 hours. Platinum compounds
similar to

, but with varying degrees of bulk surrounding the central

molecule, have been reacted with N-AcMet and 5’-GMP, yet the formation of an
analogous product was not observed.
Keywords: Platinum Compounds, 5’-GMP, N-acetylmethionine, DNA, proteins, NMR
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CHAPTER 1
INTRODUCTION
Cancer is defined as abnormal cell proliferation. It occurs when abnormal
cells divide without control, and these cells also have the ability to invade other
tissues. It begins in the cell, which is the basic unit of life, and occurs due to damage
of the DNA. It is spread throughout the body through the circulatory and lymphatic
systems. Cancer is not one specific disease; it is a multitude of varying diseases each
affecting a different type of tissue (Howlader et al., 2013). Due in part to the
relatively recent discovery of successful platinum anti-cancer drugs, the death rates
for all cancers combined for men and women of all major races and ethnicities is
declining (Ahmedin et al., 2013). Yet, despite these advancements there will be an
estimated occurrence of 1,660,290 new cases of cancer in the United States in the
year 2013 (Howlader et al., 2013).
The anticancer properties of cisplatin were accidentally discovered in the
1970’s by Barnett Rosenburg at Michigan State University. He was investigating if
magnetic or electric dipoles were involved in cell growth. When he applied the
electromagnetic radiation the cells appeared as very long filaments, instead of short
rods. The effect was shown to be due not to the electric field but the platinum
electrodes and the electrolysis products that they formed (Kelland, 2007). Since
1

then it has become one of the leading treatments for cancer. Cisplatin was the first
platinum based anticancer drug approved by the FDA and carboplatin was the
second. The mechanism of cisplatin’s anticancer properties is due to the fact that it
can covalently bond to purine DNA bases. This bonding forms platinum DNA
adducts, which then leads to the blockage of the replication and transcription
mechanism, and programmed apoptosis.
Cisplatin interacts and binds with DNA based on the Hard Soft Acid Base
(HSAB) theory. This theory states that hard acids and hard bases will react fastest
with and bind strongest to each other; while soft acids and soft bases react fastest
and strongest with each other. Elements categorized as hard are small in size, have a
high charge, are weakly polarizable, and have a high electronegativity. Soft elements
are large in size, have low charge, are strongly polarizable, and have a low
electronegativity. Platinum is considered a soft acid, and sulfur is considered a soft
base. Polarizability in this case is defined as the degree to which a molecule or ion is
easily distorted by interaction with another molecule or ion. Electrons of easily
polarizable molecules are easily distorted by interactions with other molecules or
ions (Meissler,Tarr, 2011). The HSAB theory states that these two soft acids will
prefer to react with one another. This theory explains why cisplatin and other
platinum containing cancer drugs bind to the N-7 position of guanine bases. The
nitrogen atom of the guanine molecule is in this case considered a soft base, and
therefore reacts with platinum which is a soft acid. This N-7 atom is also the most
nucleophilic site on guanine, and it is also free to bond with different compounds
due the fact that it does not bind to any DNA bases on the opposite strand. Cisplatin
2

generally binds to two adjacent guanine bases on the same strand of DNA and forms
a 1,2-intrastrand cross-link. It can occasionally be found forming adducts with
adjacent guanine and adenine molecules, and rarely with two adjacent adenine
molecules on the same strand. It forms a monofuctional adduct, which closes by
binding to the N-7 position of an adjacent purine and forms a cross link. Protein
folding into the tertiary structure involves the formation of disulfide bonds. Two
amino acids contain sulfur: cysteine and methionine. N-acetylmethionine contains
sulfur and therefore is a primary protein target for this platinum compounds and
mediates its ability to gain entrance into a cell.
The fact that cells can develop resistance during the duration of the treatment
drove further research in the area of anticancer drugs (Kelland, 2007).This expanse
in research led to the creation of oxaliplatin, satraplatin, and picoplatin. Oxaliplatin
has been found to be most effective at treating colorectal cancers, satraplatin is used
experimentally for treating prostate cancers, and picoplatin was designed to
overcome resistance and accurately treats colorectal cancer (Kelland, 2007). Of the
previously listed anticancer drugs only oxaliplatin is currently approved by the FDA.
Current chemotherapy drugs affect cancers cells, yet they also interact with normal,
healthy cells in the body. The reaction with the non-cancerous cells in the body is
what causes chemotherapy drugs to be considered toxic (Sandlin et al., 2010).
Continued research is focused on creating a more accurate and less toxic forms of
cancer treatment. The current drugs available today are accompanied with
undesirable side effects such as nephrotoxicity, ototoxicity, neurotoxicity, and

3

emesis. These harsh and damaging side effects are what drive research in this area
today.

Figure 2:

Figure 1:

Figure 1 is the structure of Cisplatin
(cis-diamminedichloroplatinum(II)).
Figure 3

Figure 2 is the structure of
(
) Cl, the compound
that was the focus of this study.
Figure 4:

Figure 3: Shows the structure of N-actetylmethionine.
Figure 4: Shows the structure of 5’-GMP.

The structure of cisplatin shows an equal distribution around the central platinum
atom, with an ammonia and chloride attached on each side. Previous experiments
have studied how different amounts of bulk on the platinum compound effect the
reaction with N-acetylmethionine and guanosine 5’-monophosphate (5’-GMP). The
platinum compound [Pt(dien)(
faster with N-acetylmethionine.

)

which has no bulk on either side reacted
dien [N,N,N’,N’,N’’4

pentamethyldiethylenetriamine) which has bulk on both sides reacted faster with
5’GMP. (Sandlin, et al., 2010). The current project is concerned with discovering
how having a large nitrogen containing ligand on one side of Chloro[N,Ndiethyldiethylenetriamine] Platinum(II) Chloride (

) will affect the reaction

with N-acetylmethionine and 5’-GMP. It was originally hypothesized that Nacetylmethionine would displace the chlorine molecule and bond to

at a

very fast rate. Then the N-acetylmethionine would be displaced by 5’-GMP, which
binds more strongly to platinum but at a slower rate. The data indicates that this is
not the case.

5

CHAPTER 2
MATERIALS AND METHODS
Synthesis of Pt Compounds: The platinum compound was made from a multistep
synthesis process. 300 mg of

was dissolved in 30mL of

. Then 1 mL of

N,N-diethyldiethylenetriamine was added. Concentrated HCl was added to adjust
the solution to pH of 3. This solution was refluxed for 24 hours. The yellow solution
that resulted was gravity filtered and dried on the rotary evaporator with a starting
temperature of 30

. The temperature was raised to 35 degrees Celsius. 4 mL of

concentrated solution resulted and was then refrigerated for 24 hours. A yellow
precipitate formed. This yellow precipitate was vacuum filtered and ethanol was
added to remove as much product as possible. The solution was then dried for three
days. The sample was then dissolved in 3.5 mL of

, heated, filtered, and then

refrigerated. When removed from the refrigerator a yellow solid had formed. 53.7
mg of [Chloro[N,N-diethyldiethylenetriamine] Platinum(II) Chloride] was
synthesized.
Synthesis of Platinum N-AcMet Solution: The following solutions were made in
different ratios. For the 1:1 N-AcMet platinum reaction 4.3 mg of the platinum
compound and 1.9 mg of N-AcMet were combined in 1.0 mL of

. For the 2:1 N-

AcMet platinum reaction 4.3 mg of the platinum compound and 3.8 mg of N-AcMet
6

were combined in 1.0 mL of

. The pH of these reactions stayed consistently

around 2.
Synthesis of Platinum 5’-GMP Solutions: The following solutions were made in
different ratios. For the 1:1 5’-GMP platinum reaction 4.3 mg of the platinum
compound and 4.1 mg of 5’-GMP were combined in 1.0 mL of

. In the 2:1 5’-GMP

platinum reaction 8.2 mg of 5’-GMP and 4.3 mg of the platinum compound were
combined in 1.0 mL of

. The pH 1:1 ratio reaction was 5.55 and the pH of the 2:1

reaction was 6.33 after the course of four days. On the fourth day the pH of each
reaction was lowered to 3.7.
Synthesis of Platinum N-AcMet and 5’-GMP solution: 4.3 mg of the platinum
compound and 1.9 mg of N-AcMet were combined in 1.0 mL of

. 4.1 mg of 5’-

GMP were added at varying stages throughout the reaction.
NMR Spectroscopy: The reactions of the platinum compound and DNA protein
complexes were analyzed using

NMR spectroscopy. The data was attained on a

JEOL Eclipse 500 MHz NMR instrument. Through analysis of the spectra obtained
via NMR spectroscopy were able to discern the displacement and binding that
occurred around the central platinum atom of
Liquid Chromatography-Mass Spectrometry: The samples were diluted by 100: 1
concentration; 10 µL of solutions were added to 1000 µL of distilled water. The
samples were then analyzed by liquid chromatography/mass spectrometry.
Ionization was operated in a positive mode ion, the ion spray used was 5200 V and
the orifice voltage applied was 10 V. The data was attained on a Varian LC/MS 500
7

Ion Trap. Using a mass-to-charge ratio this instrument enables us to be able to
distinguish the various products in our reaction from each other. The experiment
parameters used positive ion mode. When ionizable groups picked up an extra
protein that is seen as the M+1 peak, fragments were also visible. Fragments
occurred when an ionizable group picks up a sodium ion instead of a hydrogen, if a
water molecule is lost, and when the HCl is lost no charge difference is seen just a
change in mass.

8

CHAPTER 3
RESULTS
(

Reaction of

)

Cl and 5’-GMP: The [Pt(Et2dien)Cl]Cl sample was

prepared, and the identity and purity was confirmed by 1H NMR spectroscopy
(Figure 4). All platinum solutions were made as a 10mM solution, using 1.0 mL of
and 4.3 mg of

(

)

Cl. The reaction of

(

)

Cl with 5’-GMP

at both 1:1 and 2:1 ratios, meaning there were two 5’-GMP molecules per every
(

)

Cl, yielded the same product. The 5’-GMP molecule displaced the

chloride atom on [

(

)

Cl and a mono product was formed (Figure 5). The

tall, sharp singlet at 8.0 ppm and 5.75ppm represent the unreacted 5’GMP in
solution. Over time peaks at 8.4 ppm, 5.7, and 5.85 ppm grew, and those peak
represent the mono product described above. As time passed, and the reaction
occurred, the peaks representing the unreacted 5’-GMP became shorter, and the
peaks representing the mono product grew taller leading us to predict that the
formation of this product was occurring. No further reaction occurred as the peaks
did not change after the formation of the mono product had drawn to completion.

9

Figure: 5

ppm
Figure 5: Shows the NMR spectra of

10

(

)

Cl.

Figure 6:
1:1 ratio

12 days

7 days

5 days

15 mins

1:2 ratio

Figure 6: Left column shows the NMR spectra of the Platinum 5’-GMP 1:1
ratio reaction. The right column shows the NMR spectra of the Platinum 5’GMP 1:2 ratio. The comparison of these spectra shows that the same product
is formed in both reactions. The 5’-GMP displaces the chloride and binds to
the platinum and the reaction is over.
11

Reaction of

(

(

with

)
)

Cl with N-AcMet: The addition of N-AcMet

Cl led to the formation of both a mono product and bis product.

The reaction with a 1:1 ratio of

to N-AcMet leads to the formation of the

mono product, [Pt(Et2dien)(N-AcMet)]+. The N-AcMet binds to the platinum atom of
the

(

)

Cl molecule and displaces the chloride atom. This reaction

proceeds relatively fast and is usually finished in approximately 2 hours as can be
seen in Figure 7. The mono product appears as a sharp singlet at 1.9 ppm using, and
a broader singlet at 2.2 ppm. In the 2:1 ratio of N-AcMet to
reaction, meaning that there was one

(

)

(

)

Cl

Cl molecule for every N-AcMet,

both the mono and bis ([Pt(Et2dien)(N-AcMet)2]) products are formed. The mono
product forms when the chloride is displaced, yet a second N-AcMet displaces one of
the nitrogen atoms of the Et2dien chelate. There is only one coordination site
available on

(

)

Cl the N-AcMet comes in first and binds, therefore when

the second N-AcMet binds it must be displacing something other what is already
bound at the at the primary binding site, where the chloride was originally bound.
This addition of a second N-AcMet allows the formation of the bis product to occur.
This addition of the second N-AcMet occurs at a slower rate than the addition of the
first. Figure 7 shows that the formation of the bis product has begun to occur in the
same two hour time frame, yet the reaction has not drawn to completion, therefore
this reaction occurs slower than the formation of the mono product. The bis product
occurs as a multiple singlets due to stereochemistry located near 2.4 ppm.

12

Figure 7:
1:2 ratio

2 hours

1.5 hours

45 mins

5 mins

1:1 ratio

(
) Cl NFigure 7: Left column shows the NMR spectra of the 1:1
AcMet ratio reaction over time and the formation of the monoproduct. The
(
) Cl N-AcMet
right column shows the NMR spectra of the 1:2
ratio reaction and the formation of the bis product.
13

Bis product
Figure 8

Unreacted N-AcMet

Bis product

Mono
product

Figure 8 shows the formation of the mono and bis products when
(
) Cl is reacted in a 1:2 ratio with N-AcMet.

Reaction of

(

reacts faster with

)
(

Cl N-AcMet and 5’-GMP: In this reaction the N-AcMet
)

Cl and replaces the chloride ion forming the same

mono product as is seen in Figure 6 at 1.9 and 2.2 ppm in the 1:1

(

)

Cl

and N-AcMet reaction described above ([Pt(Et2dien)(N-AcMet)+). Yet, 5’-GMP comes

14

in and displaces the nitrogen atom of the

(

)

Cl chelate; this forms the N-

AcMet 5’-GMP product, [Pt(Et2dien)(N-AcMet)(5’-GMP)].

Figure 9

N-AcMet 5’-GMP
Product

Figure 9 shows the
NMR spectra for the N-AcMet 5’-GMP Product. This
spectrum shows the formation of peaks between 2.0 ppm and 3.5 ppm,
which are not seen in the spectra of the other two reactions.

15

% Intensity

Figure 10

M/Z

M/Z

Figure 10: Shows the mass spectrometry results. Peak at m/z = 544 is
mono product with methionine; peak at m/z=907 is N-AcMet/GMP
product.
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CHAPTER 4
DISCUSSION
The purpose of this experiment was to see what effect having a large nitrogen
containing ligand around the central platinum atom would have on have the
compounds ability to react with N-AcMet and 5’-GMP. We synthesized
the

(

)

Cl and reacted it individually with N-AcMet, 5’-GMP, and a

mixture of N-AcMet and 5’-GMP. The results obtained from a 1:1 reaction of
(

)

Cl and 5’-GMP showed the displacement of the chloride ion by 5’-

GMP and the formation of a monoproduct as was predicted. The results obtained
from a 1:1 reaction of

(

)

Cl and N-AcMet showed again the

displacement of the chloride ion and the formation of a monoproduct as was
predicted. When we reacted

(

)

Cl, 5’-GMP, and N-AcMet the results

indicated the formation of new product we had not expected. We predicted that the
N-AcMet would react faster and displace the chloride ion as was seen in the 1:1
and N-AcMet reaction. Then the 5’-GMP which reacts slower, yet binds
stronger to the central platinum ion would then come in displace the N-AcMet.
Similar reactivity has been previously observed for [Pt(dien)Cl]Cl ( Barnham et al.,
1994, Djuran et al., 1991).

17

The product that formed from the reaction of all three indicated that the 5’-GMP
and N-AcMet were both bound to the central platinum atom and it was the nitrogen
ligand was displaced. By comparison, [Pt(

dien)(N

) , which has significant

steric clashes with N-AcMet and thus reacts faster with 5’-GMP, does not show a
displacement of a portion of the

dien ligand when 5’-GMP is added after the N-

AcMet is able to react. This led us to perform the 1:2
and 1:2

(

(

)

Cl to N-AcMet,

Cl 5’-GMP reactions to see if the formation of this product

)

was unique to this platinum compound, or was linked to the reagents used and
order they were presented. We found that when a second equivalent of N-AcMet is
added to

(

)

Cl, a second product is eventually observed after the

formation of some [Pt(Et2dien)(N-AcMet)]+ occurs. We believe two N-AcMet
molecules are coordinating to the platinum, with the second N-AcMet replacing one
of the nitrogen atoms of

in the coordination sphere.

We think that when N-AcMet binds to the central platinum atom the steric strain
is so large that the when 5’-GMP, or another N-AcMet is present the nitrogen
containing ligand is knocked off and either the 5’-GMP, or in the 2:1 N-AcMet NAcMet bind where the nitrogen ligand was. This formation must be more stable than
the original conformation, to cause the nitrogen containing ligand to dissociate from
the central platinum atom. The formation of either the N-AcMet bis product or the
Platinum N-AcMet 5’-GMP product with the large nitrogen ligand hanging from the
side leads us to believe that this compound may have anticancer properties, with the
large nitrogen ligand being able to block DNA transcription and replication
enzymes. Phenanthriplatin, cis-Pt(N

) (phenanthridine)Cl, has been shown to
18

have significant anticancer activity due in part to the large phenanthridine ligand
attached to the platinum atom (Park et al. 2012). This platinum complex binds to
DNA and blocks transcription, leading to cytotoxicity in a number of cancer cell lines
at lower doses than cisplatin. The Et2dien complex has a similar size to
phanenthriplatin, and thus we plan to test the cytotoxicity of this compound in the
near future.

Figure 11

+

(
) Cl and
Figure 11: Shows the reaction scheme for the
N-AcMet 1:1 reaction; it shows the formation of the mono product.
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Figure 12

+

2

Figure 12: Shows the 1:2 ratio reaction scheme of
and N-AcMet, and the formation of the bis product.

(

)

Cl

Figure 13

+

(
) Cl
Figure 13: Shows the product of the 1:1 reaction of
and 5’-GMP. The same product is seen in the 1:2 ratio reaction as well.
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Figure 14

+

+

Figure 14: Shows the formation of the Pt N-AcMet-5’-GMP product and the
(
) Cl is first
displacement of the nitrogen containing ligand.
reacted with N-AcMet, and then with 5-GMP as can be seen above.
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